WhiteLab Genomics: Funding, Investors & Team (Sep 2026)
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.
WhiteLab Genomics has raised $10.0M across 1 funding round on record, the most recent a Seed of $10.0M announced in Sep 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
WhiteLab Genomics Company Profile and Key Stats
Latest funding round on record: Sep 2022.
WhiteLab Genomics Funding Rounds
WhiteLab Genomics Founders and Leadership Team
No contact details are on record for this team yet.
WhiteLab Genomics Funding Compared to Other Biotechnology Startups
WhiteLab Genomics' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like WhiteLab Genomics in Biotechnology and Paris
Companies Similar to WhiteLab Genomics
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
WhiteLab Genomics Funding FAQs
What does WhiteLab Genomics do?
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.
How much funding has WhiteLab Genomics raised?
WhiteLab Genomics has raised $10.0M across 1 round on record. The most recent is a Seed of $10.0M announced in Sep 2022.
When did WhiteLab Genomics last raise funding?
WhiteLab Genomics' most recent funding round on record is a Seed of $10.0M, announced in Sep 2022.
Who is the CEO of WhiteLab Genomics?
David Del Bourgo is listed as CEO at WhiteLab Genomics.
Where is WhiteLab Genomics headquartered?
WhiteLab Genomics is based in Paris, Ile-De-France, France.
How many employees does WhiteLab Genomics have?
WhiteLab Genomics is in the 11-50 employee band.
How does WhiteLab Genomics' funding compare to other Biotechnology startups?
WhiteLab Genomics' latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's WhiteLab Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for WhiteLab Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.